FDA panel votes unanimously in favor of Horizon's thyroid eye disease drug

Independent advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor of Horizon Therapeutics Plc's experimental treatment for thyroid eye disease (TED), taking the drug a step towards potential approval.